Atorvastatin generally begins to work within LDL response measurable at 4 weeks, with the effect lasting 24-hour dosing. The exact timing depends on dose, food, formulation and individual metabolism.
Key takeaways
- Typical onset: LDL response measurable at 4 weeks.
- Duration of effect: 24-hour dosing.
- Dosing pattern: 10–20 mg nightly, titrated to LDL target.
- Delays are usually explained by food, dose or an unrealistic expectation of the endpoint.
Atorvastatin timeline
| Stage | When | What to expect |
|---|---|---|
| First dose | Day 1 | Absorption begins; the pharmacological effect appears within LDL response measurable at 4 weeks. |
| Early phase | Week 1–2 | Tolerability is established. Mild myalgia is most common now. |
| Assessment point | Week 4 | Prescribers judge response and decide whether to hold or titrate. |
| Steady state | Week 8–12 | Full therapeutic benefit for hyperlipidaemia and cardiovascular risk reduction is judged here. |
What slows it down
A heavy or high-fat meal, an under-titrated dose, missed doses and interacting medicines all delay the response to Atorvastatin. Storage matters too: product held outside below 30 °C can lose potency before it reaches the patient.
When to reassess
If there is no benefit after a full trial at the licensed dose, the standard next steps are dose escalation within range, adherence review, or a switch to Rosuvastatin.
Atorvastatin at a glance
| Attribute | Detail |
|---|---|
| Drug class | HMG-CoA reductase inhibitor |
| Common brand | Lipitor |
| Licensed use | hyperlipidaemia and cardiovascular risk reduction |
| Available strengths | 10, 20, 40, 80 mg |
| Dosage form | film-coated tablet |
| Typical onset | LDL response measurable at 4 weeks |
| Duration / dosing interval | 24-hour dosing |
| Storage | below 30 °C |
